Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (i) New outpatient clients, age at first use distribution by primary drug (%)

Substance	<15	15–19	20–24	25–29	30–34	35–39	40–44	45+	Mean age	Age known (base)	Age not known
Opiates	6.7	38.0	30.0	12.9	6.4	3.1	1.5	1.3	22.4	29464	5049
Cocaine	8.4	38.3	26.7	13.2	6.7	3.9	1.9	1.0	22.4	25470	2422
Stimulants	14.9	54.3	18.3	6.3	3.1	0.8	0.8	1.6	20.0	3352	435
Hypnotics and sedatives	8.6	22.6	15.9	11.9	10.2	11.6	9.1	10.1	29.0	1085	229
Hallucinogens	6.4	20.3	13.4	10.9	9.3	9.0	10.0	20.8	32.1	659	134
Volatile substances	38.2	27.6	15.6	2.5	9.5	0.0	4.5	2.0	20.4	199	26
Cannabis	38.8	48.7	8.3	2.4	0.9	0.5	0.2	0.2	17.0	25384	3588
Other substances	21.7	32.7	17.0	5.2	7.0	8.7	3.5	4.2	23.4	575	912
Total	17.2	41.5	21.7	9.5	4.8	2.7	1.4	1.2	20.9	86188	12795

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, RO, SI, SK, FI, SE, HR 

 Last data available from Spain refer to 2007, for Malta refer to 2006 and for Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7. 

 See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)